- Home
- LEGO vs SRZN Comparison
LEGO vs SRZN Comparison
Compare LEGO & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$9.97
HOLD
Current Price
$20.79
Company Overview
Basic Information| Metric | LEGO | SRZN |
|---|---|---|
| Founded | 2025 | 2015 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Steel/Iron Ore | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.2M | 271.6M |
| IPO Year | 2026 | N/A |
Fundamental Metrics
Financial Performance| Metric | LEGO | SRZN |
|---|---|---|
| Price | $9.97 | $20.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | 24.1K | ★ 169.9K |
| Earning Date | N/A | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $75.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.80 | $8.21 |
| 52 Week High | $9.97 | $35.00 |
Technical Indicators
Market Signals| Indicator | LEGO | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 65.19 | 32.29 |
| Support Level | $9.84 | $20.26 |
| Resistance Level | N/A | $21.40 |
| Average True Range (ATR) | 0.01 | 1.80 |
| MACD | 0.00 | -0.25 |
| Stochastic Oscillator | 100.00 | 1.79 |
Price Performance
Historical Comparison LEGO
SRZN
About LEGO Legato Merger Corp. IV Ordinary Shares
Legato Merger Corp IV is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).